Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients
暂无分享,去创建一个
[1] F. Buccisano,et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. , 2008, Blood.
[2] Benjamin Haibe-Kains,et al. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. , 2007, Clinical chemistry.
[3] J. Philippé,et al. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. , 2007, Clinical chemistry.
[4] F. Menestrina,et al. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor , 2007, Leukemia.
[5] S. Deaglio,et al. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. , 2006, Blood.
[6] V. Gattei,et al. ZAP‐70 expression in B‐cell chronic lymphocytic leukemia: Evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgVH mutations , 2006, Cytometry. Part B, Clinical cytometry.
[7] B. Saka,et al. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia. , 2006, Clinical and laboratory haematology.
[8] W. Graveland,et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. , 2006, Haematologica.
[9] S. Johnson,et al. Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. , 2005, Clinical and laboratory haematology.
[10] F. Davi,et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. , 2005, Blood.
[11] H. Döhner,et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia , 2005, Leukemia.
[12] Nikolaos Laoutaris,et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.
[13] Arthur Weiss,et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.
[14] Adrian Wiestner,et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.
[15] Adrian Wiestner,et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.
[16] Emili Montserrat,et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.
[17] G. Guida,et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. , 2003, Blood.
[18] D. Oscier,et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. , 2002, Blood.
[19] H. Döhner,et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. , 2002, Blood.
[20] Göran Roos,et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.
[21] D. Oscier,et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.
[22] Richard Greil,et al. The Role of Soluble CD23 in Distinguishing Stable and Progressive Forms of B-chronic Lymphocytic Leukemia , 2002, Leukemia & lymphoma.
[23] R. Bataille,et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia , 2002, British journal of haematology.
[24] A. Domingo-Clarós,et al. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. , 2002, Haematologica.
[25] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[26] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[27] K. Döhner,et al. Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia , 1998, Annals of Hematology.
[28] E. Thiel,et al. Prognostic impact of the serum levels of soluble CD23 in B-cell chronic lymphocytic leukemia. , 1997, Blood.
[29] H. Döhner,et al. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. , 1997, Leukemia.
[30] S. Chevret,et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. , 1996, Blood.
[31] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.
[32] C. Gasche,et al. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] S. Fournier,et al. The Low‐Affinity Receptor for IgE , 1992, Immunological reviews.
[34] R. Levy,et al. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. , 1992, Molecular immunology.
[35] L. Lagneaux,et al. Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. , 1988, Blood.
[36] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[37] Ciril Rozman,et al. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance , 1986, British journal of haematology.